Name Funds
holding
Growth Growth % Return since
31 Mar ‘22
6401
14 -3 -18% 87.2%
6402
14 -3 -18% 62.3%
6403
28 -6 -18% 100%
SABS icon
6404
SAB Biotherapeutics
SABS
$275M
28 -6 -18% 90.4%
6405
23 -5 -18% 76.5%
6406
69 -15 -18% 146%
6407
648 -141 -18% 5.3%
6408
188 -41 -18% 86.6%
6409
41 -9 -18% 20.4%
6410
50 -11 -18% 72%
ACRS icon
6411
Aclaris Therapeutics
ACRS
$640M
109 -24 -18% 73.4%
6412
9 -2 -18% 100%
6413
9 -2 -18% 25%
6414
9 -2 -18%
6415
9 -2 -18% 28.4%
6416
9 -2 -18% 47.5%
6417
18 -4 -18% 86.9%
6418
18 -4 -18% 166%
6419
18 -4 -18% 100%
6420
27 -6 -18% 40.7%
6421
27 -6 -18% 100%
6422
27 -6 -18% 100%
6423
36 -8 -18% 38.6%
6424
36 -8 -18% 45.1%
6425
36 -8 -18% 26.8%